期刊文献+

2型糖尿病患者硒蛋白P和胰岛素抵抗的相关性 被引量:5

Selenoprotein P in type 2 diabetes mellitus and its association with insulin resistance
原文传递
导出
摘要 目的:研究健康人和2型糖尿病患者中硒蛋白P ( SEPP )和胰岛素抵抗的相关性。方法入组门诊初发2型糖尿病患者156例和64名健康人作为对照,测定空腹血糖( FPG)、空腹胰岛素( FIN)、血脂谱、SEPP 水平,记录身高、体重和血压,采用稳态模型评估胰岛素抵抗指数(HOMA-IR)和计算胰岛素敏感性指数(ISI)。结果(1)肥胖和非肥胖糖尿病组的SEPP水平均显著高于对照组[(4.43±1.95)、(3.01±1.20)比(2.34±2.30)mmol/L,均P<0.01],肥胖糖尿病组的SEPP水平高于非肥胖糖尿病组(均P<0.05)。(2)在总队列人群中SEPP水平和FIN、FPG、体质指数(BMI)、甘油三酯(TG)和HOMA-IR呈正相关(r=0.401、0.202、0.420、0.239、0.445,均P<0.05)和ISI呈负相关(r=-0.414,P<0.01)。(3)多元逐步回归分析显示,影响胰岛素抵抗的主要因素为SEPP水平(β=0.293,P<0.01)。影响ISI的主要因素为收缩压、HbA1c和SEPP水平(β=-0.195、-0.185、-0.246,均P<0.05)。结论血清SEPP水平不受年龄、血压、血脂等影响,是胰岛素抵抗的独立影响因素。 Objective To explore the relationship between selenoprotein P ( SEPP ) and insulin resistance in subjects with normal glucose tolerance and type 2 diabetes mellitus .Methods A total of 156 subjects with newly onset diabetes and 64 subjects with normal glucose tolerance were enrolled .Fasting plasma glucose ( FPG ) , fasting insulin ( FIN ) , lipid profile and SEPP level were measured and height , weight and blood pressure were recorded.Insulin resistance index was calculated by homeostatic model assessment ( HOMA-IR).Results The SEPP level was significantly higher in obese and non-obese diabetic groups than control group ((4.43 ±1.95), (3.01 ±1.20) vs (2.34 ±2.30)mmol/L, both P〈0.01).The SEPP level was significantly higher in obese subgroup of diabetic group than non -obese subgroup ( P〈0.05).The SEPP level was positively correlated with FIN , FPG, body mass index (BMI), triglycerides (TG) and HOMA-IR (r=0.401, 0.202, 0.420, 0.239, 0.445, P〈0.05) and negatively with ISI (r=-0.414, P 〈0.01 ).Multivariate regression analysis demonstrated that SEPP level was independently correlated with insulin resistance (β=0.293, P〈0.01).And the independent factors for ISI were systolic pressure, HbA1c and SEPP level (β=-0.195, -0.185 and -0.246, P〈0.05).Conclusion Serum SEPP level may be an independent risk factor for insulin resistance regardless of age , blood pressure or lipid profile.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第22期1710-1713,共4页 National Medical Journal of China
基金 基金项目:上海市卫生局青年科研基金(20124y105)
关键词 糖尿病 2型 硒蛋白P 胰岛素抵抗 Diabetes mellitus,type 2 Selenoprotein P Insulin resistance
  • 相关文献

参考文献15

  • 1Burk RF, Hill KE. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis [ J]. Annu Rev Nutr,2005,25 : 215-235.
  • 2Zeng MS, Li X, Liu Y, et al. A high-selenium diet induces insulin resistance in gestating rats and their offspring. Free Radic[ J]. Biol Med ,2012,52 : 1335-1342.
  • 3Yang S J, Hwang SY, Choi HY, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis [ J ]. J Clin Endocrinol Metab,2011,96 : E1325-E1329.
  • 4Srinivas PR, Wagner AS, Reddy LV, et al. Serum ct2-HS- glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level[ J ], Mol Endocrinol, 1993, 7 : 1445-1455.
  • 5Oike Y, Akao M, Yasunaga K, et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance [ J ].Nat Med, 2005,11 : 400-408.
  • 6Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator [ J]. J Clin Invest, 2005,115 : 1627- 1635.
  • 7Raymond FB, Kristina EH. Selenoprotein P - expression, functions, and roles in mammals[J]. Biochim Biophys Acta ,2009, 1790 : 1441-1447.
  • 8Stapleton SR. Selenium : an insulin-mimetic [ J ]. Cell Mol Life Sci,2000,57 : 1874-1879.
  • 9Mueller AS, Pallauf J. Compendium of the antidiabetie effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice[ J]. J Nutr Bioehem,2006,17: 548 -560.
  • 10Hirofumi M, Toshinari T, Hiroaki T. A liver-derived secretory protein, selenoprotein P, causes insulin resistance [ J]. Cell Metabolism,2010,12 : 483-495.

同被引文献54

  • 1弋花妮,李娟,白晶,孙茜,彭婷.妊娠期糖尿病与胰岛素抵抗[J].中国妇幼健康研究,2006,17(3):181-184. 被引量:14
  • 2张彩丽.短期持续皮下胰岛素输注联合磷酸西格列汀治疗初诊2型糖尿病的临床研究.江苏大学,2013.
  • 3杜强,王艳军,杨生,等.磷酸西格列汀对2型糖尿病患者Apelin水平的影响.中华临床医师杂志(电子版),2013(22):10021-10024.
  • 4Williams-He.nan D, Johnson J, Teng R, et al. Efficacy and safety of Sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes. Diabetes Obes Metab, 2010, 12(5):442-451.
  • 5白博丽,杨良栋.地特胰岛素联合磷酸西格列汀治疗2型糖尿病的l临床疗效观察.中国保健营养(中旬刊),2014,24(2):715.
  • 6Rui L. Energy metabolism in the liver. Compr Physiol, 2014, 4:177-197.
  • 7Despr6s JP, Lamarche B, Mauri6ge P, et al. Hyperinsu- linemia as an independent risk factor for ischemic heart disease. N Engl J Med, 1996, 334:952-957.
  • 8Ota T, Takamura T, Kurita S, et al. Insulin resistance ac- celerates a dietary rat model of nonalcoholic steatohepa- titis. Gastroenterology, 2007, 132:282-293.
  • 9Berry MJ, Banu L, Chen YY, et al. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature, 1991, 353:273-276.
  • 10Hill KE, Wu S, Motley AK, et al. Production of seleno- protein P (Seppl) by hepatocytes is central to selenium homeostasis. J Biol Chem, 2012, 287:40414-40424.

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部